Remove Business Development Remove Development Remove Doctors Remove Pharma Companies
article thumbnail

VivoPlex raises funding to develop intra-uterine sensor

pharmaphorum

to develop an intra-uterine sensor system and generate clinical data that could be used for European approval. The Future Fund participated in the second tranche of the fundraising alongside other investors, unlocking matched financing and helping to drive the business forward towards commercialisation.

article thumbnail

Why pharma isn’t yet achieving digital excellence, and how it can get there

pharmaphorum

Meanwhile, field teams’ promotional content is still reflective of the pre-COVID paradigm, and Noel says companies need to rethink what content messages will be beneficial for HCPs. Reps should not just be pushing product messages – they should be asking doctors what they need right now and how they can help.”.

Sales 131
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Hollywood and the Metaverse’s effect on pharma’s content

pharmaphorum

Gaurav Kapoor, co-founder and executive vice president of Indegene, tells pharmaphorum how pharma can take lessons from the entertainment industry and prepare for the Metaverse to enhance content engagement. Pharma companies’ customer communication methods require reimagining as technology progresses.

Branding 115
article thumbnail

Philips on designing innovation and cultivating partnerships – part two

pharmaphorum

Ties Kroezen, venture leader of Community Life Centers and business development manager for Philips Africa, tells us about the challenges present within the African healthcare system, solutions the company developed to help patients and providers connect, and how pharma can assist with delivering better care to African residents.

article thumbnail

Using technology to reassess the clinical trial landscape

pharmaphorum

Many companies realise traditional clinical trial processes need modification to improve efficiency, and partnerships are forming in distinct ways to evaluate how digital therapeutics, such as VR can enhance trial designs and outcomes. He oversees operations, including business development, sales and marketing, and people.

article thumbnail

Patient involvement in trial design: looking to the future

pharmaphorum

As moderator Gareth Powell – business development officer, patient engagement and clinical development service project lead at the NIHR – noted, the Institute has seen fantastic feedback from patients on the increased use of virtual engagement over the course of pandemic. We can’t just say ‘Here’s an app, fill it in.

Trials 125
article thumbnail

Transitioning Between Academia and Industry: Advice from Leading Scientists That Made the Switch

XTalks

And although academia and industry have often been pitted against each other in the realm of scientific discovery and development, there may be more similarities and synergies between the two than we may think. WeiQi Lin, MD, PhD, executive vice president of research & development and principal scientist, DURECT Corporation.